Nov 22 • 1HR 40M

#70: How Venture Capital Supports Science And Innovation

A conversation with Bruno Montanari, Seroba Life Science

Upgrade to listen

Appears in this episode

Christian Soschner
Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Leave your eMail - https://mailchi.mp/e2467061ef75/lsg2g
Episode details
Comments

30+ Podcast Platforms | YouTube

Big corporations strive to bring new solutions to their customers to help them solve their most pressing problems.

To do so, the corporation needs to be innovative. That's why companies like Apple, Google, Pfizer, and similar players want to cooperate with start-ups and scale-ups globally.

Such cooperations strive to collaborate with top startups, invest in them, and sometimes acquire them to access novel ideas. By innovating, the big players stay competitive, secure growth, and also help keep their employees motivated and curious.

One of the best ways to foster innovation is by creating Venture Capital funds. Venture funds collect capital to invest in high-risk early-stage innovative startups to help them grow.

In this episode, we talk about:

  • Why is Venture Capital important for Innovation in Life Science?

  • What is the Secret Sauce of Venture Capital?

  • Venture Capital Success Stories

  • What is the Current Situation of Venture Capital in Europe?

  • And much more

Who is the expert in the show?

Bruno Montanari is a Partner at Seroba. He has a background in venture capital and investment banking, focusing on the pharmaceutical, biotechnology, and medical device industries.

Bruno sits on the boards of STORM Therapeutics and Coave Therapeutics.

Listen to this episode with a 7-day free trial

Subscribe to LSG2G Deep Tech Podcast Community to listen to this episode and get 7 days of free access to the full post archives.